Spatiotemporal knockout by an Adenovirus-Targeting System.

通过腺病毒靶向系统进行时空敲除。

基本信息

  • 批准号:
    10044227
  • 负责人:
  • 金额:
    $ 8.32万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

The current experiment can be dissected down into two principles. First, it is essential for the recombinational events to occur only in the cells in question (ie, injured neurons in this case). Second, it is of large benefit to restrict the number of gene manipulation before observing the outcome. When a non-restrictive promoter is used to drive the expression from the adenoviruses, we were unable to target the Cre expression solely to the axonally-damaged neurons but would widely rearrange the neighboring cells. If the gene in question is closely related to the survival and/or maintenance of a cell, it is crucial to restrict the expression in a strict temporal and spatial manner. We then tried to gain some neuronal specificity within the adenovirus' promoter. As the size matters when recombining into the expression module of an adenovirus, we initially chose the relatively small SCG10/REST system. This has led to a relatively neuronal restrictive expression of a reporter gene. Howeve … More r, when tested with a Cre expressing system, the switch of the expressivity wasn't sharp enough to restrict the recombination to the damaged neurons. We next rested transgenic mice with a pan-neuronal specific promoter such as GAP-43 or nestin enhancer. These in turn showed some problems of their own. Nevertheless, it is of utmost importance to strictly regulate the gene expression and we hope to realize this through some refinements of these. We additionally obtained some interesting insights of the role of the target genes during nerve injury. c-Jun (especially its phosphorylation) is believed to play a part in the decision of cell fate during neuronal cell death. We do agree on this principle and therefore chose the molecule for the target of our silent-knockout (=the background mice for the conditional gene targeting). In an independent experiment, we showed that an additional member of the AP-1 family, Atf-3 might be as much crucial and cooperate with c-jun during death/survival decision. We are now Flaming to apply the current experiment paradigm for this molecule as well. Less
目前的实验可以分解为两个原则。首先,重组事件必须只发生在有问题的细胞中(即,在这种情况下,受损的神经元)。其次,在观察结果之前限制基因操作的次数是很有好处的。当使用非限制性启动子驱动腺病毒的表达时,我们不能仅针对轴突损伤的神经元表达Cre,而是广泛地重排邻近细胞。如果所讨论的基因与细胞的生存和/或维持密切相关,那么以严格的时间和空间方式限制表达是至关重要的。然后,我们试图在腺病毒的启动子中获得一些神经元特异性。由于重组腺病毒表达模块时大小很重要,我们最初选择了相对较小的SCG10/REST系统。这导致了报告基因在神经元上的相对限制性表达。然而,…更重要的是,当用Cre表达系统测试时,表达能力的变化不够尖锐,不足以将重组限制在受损的神经元上。接下来,我们让带有泛神经元特异性启动子的转基因小鼠休息,比如GAP-43或Nestin增强子。这些反过来又显示出它们自己的一些问题。然而,严格调控基因表达是最重要的,我们希望通过一些改进来实现这一点。此外,我们还对靶基因在神经损伤中的作用获得了一些有趣的见解。C-jun(尤其是其磷酸化)被认为在神经细胞死亡过程中对细胞命运起着决定作用。我们确实同意这一原则,因此选择了分子作为我们沉默基因敲除的目标(=有条件基因打靶的背景鼠)。在一项独立的实验中,我们证明了AP-1家族的另一个成员ATF-3可能同样至关重要,并在死亡/生存决定中与c-Jun合作。我们现在正在努力将目前的实验范式也应用于这种分子。较少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohnuma T: "Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia."NeuroReport. 11.14. 3133-3137 (2000)
Ohnuma T:“精神分裂症患者前额皮质和海马中 PSD95 的基因表达。”NeuroReport。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tanabe K.: "Expressed-sequence-tag approach to identify differentially expressed genes following peripheral nerve axotomy"Mol. Brain Res.. 64.
Tanabe K.:“表达序列标签方法识别周围神经轴突切除术后差异表达的基因”Mol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kiryu-Seo S et al.: "Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers."Proe Natl Acad Sci. USA.. Vol.97No.8. 4345-4350 (2000)
Kiryu-Seo S 等人:“损伤诱导的神经元内肽酶 (DINE) 是一种独特的金属肽酶,在神经元损伤反应中表达并激活超氧化物清除剂。”Proe Natl Acad Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kato H.: "The Practical Transgenic Mice."Nou21. Vol.3No.4. 95-98 (2000)
Kato H.:“实用的转基因小鼠”。Nou21。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeda M: "Injury-Specific Expression of Activating Transcription Factor-3 in Retinal Ganglion Cells and Its Colocalized Expression with Phosphorylated c-Jun."Invest.Ophthalmol.Vis.Sci.. 41.9. 2412-2421 (2000)
Takeda M:“视网膜神经节细胞中激活转录因子 3 的损伤特异性表达及其与磷酸化 c-Jun 的共定位表达。”Invest.Ophasemol.Vis.Sci. 41.9。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIYAMA Hiroshi其他文献

KIYAMA Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIYAMA Hiroshi', 18)}}的其他基金

a mechanism underlying microglial activation by chronic stress
慢性应激引起小胶质细胞激活的机制
  • 批准号:
    25670093
  • 财政年份:
    2013
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanisms underlying a failure of Neuro-Endocrine-Immune system by chronic stress.
慢性压力导致神经内分泌免疫系统衰竭的机制。
  • 批准号:
    22650072
  • 财政年份:
    2010
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
An involvement of damage induced neuronal endopeptidase DINE in construction of neuro-muscular junction.
损伤诱导的神经元内肽酶 DINE 参与神经肌肉接头的构建。
  • 批准号:
    22390035
  • 财政年份:
    2010
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of a transcription factor complex which promotes nerve regeneration
促进神经再生的转录因子复合物的鉴定
  • 批准号:
    19209005
  • 财政年份:
    2007
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanism underlying promotion of neuronal regeneration
促进神经元再生的分子机制
  • 批准号:
    17300113
  • 财政年份:
    2005
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Promotion of researches for protective regeneration of injured neurons
促进损伤神经元保护性再生研究
  • 批准号:
    13307001
  • 财政年份:
    2001
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Neural species specific gene transfer by adenovirus vector.
通过腺病毒载体进行神经物种特异性基因转移。
  • 批准号:
    12558087
  • 财政年份:
    2000
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Prevention of injured neuron death by adennovirus vector.
腺病毒载体预防受损神经元死亡。
  • 批准号:
    10470001
  • 财政年份:
    1998
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
DIFFERENTIAL MECHANISM IN NERVE REGENERATION BETWEEN CNS AND PNS DIFFERENCE
CNS 和 PNS 差异的神经再生机制
  • 批准号:
    08458246
  • 财政年份:
    1996
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
PROGRAMMED KNOCKOUT MOUSE FOR THE ANALYSIS OF NEURAL ACTIVATORS.
用于分析神经激活剂的程序敲除小鼠。
  • 批准号:
    07557183
  • 财政年份:
    1995
  • 资助金额:
    $ 8.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似海外基金

Lentivirus Construct Core
慢病毒构建核心
  • 批准号:
    10630391
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
  • 批准号:
    10734709
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
  • 批准号:
    10593796
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
A novel therapeutic approach for Alzheimer Disease (AD)
阿尔茨海默病(AD)的新治疗方法
  • 批准号:
    10740016
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
  • 批准号:
    10678053
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Molecular mechanisms of load-induced t-tubule regulation in the mammalian heart
哺乳动物心脏负荷诱导 T 管调节的分子机制
  • 批准号:
    10664338
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
  • 批准号:
    10725702
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Optimizing the synthesis of[18F]FTMP for commercial distribution
优化 [18F]FTMP 的合成以进行商业分销
  • 批准号:
    10601199
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
Neuronal Regulation of Skeletal Development and Repair
骨骼发育和修复的神经元调节
  • 批准号:
    10704223
  • 财政年份:
    2023
  • 资助金额:
    $ 8.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了